{
  "id": "serotonin_syndrome_recognition_highlight_v1",
  "type": "highlight",
  "stem": "A client taking sertraline and recently started on tramadol visits the clinic. Highlight the findings that are most consistent with serotonin syndrome.",
  "passage": "The client reports feeling [agitated and restless] since starting the new medication. Upon assessment, the nurse notes [profuse diaphoresis]. Vital signs reveal a [temperature of 102.4°F], [heart rate of 118 beats/min], and [blood pressure of 162/94 mmHg]. Physical exam shows [hyperreflexia] and [spontaneous muscle clonus] in the lower extremities. The nurse observes [shivering and tremors] during the interview. The client reports [abdominal cramping and diarrhea]. When checking the eyes, the nurse notes [dilated pupils] (mydriasis). The client is [increasingly confused] and [disoriented to time].",
  "correctSpanIndices": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10
  ],
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "recognizeCues",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 4,
    "topicTags": [
      "Serotonin Syndrome",
      "Pharmacology",
      "Psychiatric"
    ]
  },
  "rationale": {
    "correct": "Serotonin syndrome is a potentially life-threatening condition resulting from excessive serotonergic activity in the central nervous system (CNS) and peripheral nervous system (PNS). Sertraline, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels by blocking its reabsorption in the synaptic cleft. Tramadol, an opioid analgesic, also possesses serotonergic properties by inhibiting serotonin reuptake and promoting serotonin release. The combination of these medications can lead to serotonin accumulation, causing a cascade of symptoms. The highlighted findings are indicative of serotonin syndrome due to the overstimulation of serotonin receptors. Agitation, restlessness, confusion, and disorientation reflect altered mental status. Autonomic hyperactivity is manifested by fever (102.4°F), tachycardia (118 bpm), hypertension (162/94 mmHg), profuse diaphoresis, dilated pupils (mydriasis), abdominal cramping, and diarrhea. Neuromuscular abnormalities include hyperreflexia, spontaneous muscle clonus, shivering, and tremors. These findings collectively suggest excessive serotonin activity affecting the CNS and PNS.",
    "incorrect": "While the medications (sertraline and tramadol) are contributing factors to the development of serotonin syndrome, they are not the direct manifestations of the syndrome itself. The highlighted findings represent the clinical signs and symptoms resulting from the excessive serotonin activity. Failing to identify these cues could delay appropriate intervention and potentially lead to adverse outcomes.",
    "clinicalPearls": "Clinical Pearl: Remember the mnemonic 'SHIVERS' - Shivering, Hyperreflexia and myoclonus, Increased temperature, Vital sign instability, Encephalopathy, Restlessness, Sweating. Early recognition and prompt intervention are crucial in managing serotonin syndrome. Discontinue all serotonergic medications immediately. Provide supportive care, including intravenous fluids, cooling measures for hyperthermia, and benzodiazepines for agitation and muscle rigidity. In severe cases, consider administering cyproheptadine, a serotonin antagonist, to block serotonin receptors. Monitor vital signs, mental status, and neuromuscular function closely.",
    "questionTrap": "While neuroleptic malignant syndrome (NMS) shares some overlapping symptoms with serotonin syndrome, key differentiating factors include the presence of 'lead-pipe' rigidity in NMS versus clonus and hyperreflexia in serotonin syndrome. Also, NMS is typically associated with antipsychotic medications, while serotonin syndrome is linked to serotonergic agents.",
    "reviewUnits": [
      {
        "heading": "Serotonin Syndrome: Signs and Symptoms",
        "body": "Mental Status Changes: Agitation, anxiety, confusion, disorientation. Autonomic Dysfunction: Hyperthermia, tachycardia, hypertension, diaphoresis, mydriasis, vomiting, diarrhea. Neuromuscular Abnormalities: Tremor, muscle rigidity, myoclonus, hyperreflexia, clonus."
      },
      {
        "heading": "Serotonin Syndrome: SBAR Communication",
        "body": "Situation: Client presenting with agitation, diaphoresis, and elevated vital signs after starting tramadol while taking sertraline. Background: Client has been on sertraline for depression and recently started tramadol for pain management. Assessment: Findings consistent with serotonin syndrome: temperature 102.4°F, heart rate 118 bpm, blood pressure 162/94 mmHg, hyperreflexia, clonus, dilated pupils, confusion. Recommendation: Discontinue serotonergic medications immediately. Administer supportive care (IV fluids, cooling measures, benzodiazepines). Consider cyproheptadine if symptoms are severe. Monitor vital signs and mental status closely. Notify provider immediately at 1545."
      }
    ],
    "answerBreakdown": [
      {
        "label": "Critical Cues",
        "content": "The identified evidence represents objective clinical markers of physiological instability indicative of serotonin syndrome. These cues necessitate immediate intervention to prevent further complications.",
        "isCorrect": true
      }
    ],
    "mnemonic": {
      "title": "HARM",
      "expansion": "Hyperthermia, Autonomic instability, Rigidity/hyperreflexia, Mental status changes"
    }
  },
  "scoring": {
    "method": "plus-minus",
    "maxPoints": 11
  },
  "createdAt": "2026-02-13T15:37:24Z",
  "sentinelStatus": "healed_v2026_v11"
}